Article Details

Applied DNA Sciences Sees Modest Revenue Growth in Q2 2025 - WebDisclosure

Retrieved on: 2025-05-16 08:13:37

Tags for this article:

Click the tags to see associated articles and topics

Applied DNA Sciences Sees Modest Revenue Growth in Q2 2025 - WebDisclosure. View article details on hiswai:

Excerpt

Applied DNA Sciences, Inc. (NASDAQ:APDN) reports a 44% Y/Y increase in LineaRx segment revenues contributing to a 6% total revenue growth.

Article found on: www.webdisclosure.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo